Sensitive ASX Announcement

Telix Preclinical Development of Radiolabelled Olaratumab

Published: 17/04/23, 08:23am (AEST)3 pages
Telix Pharmaceuticals Limited
TLX:ASXHealthcare

Recent TLX Announcements

Price Sensitive only